E89R
TEAS SECTION 8 & 9 RECEIVED
07/02/2026
Back to search
Official data from USPTO
JAZZ PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
JAZZ PHARMACEUTICALS
ST13
US500000086661335Class
5
Filing
86661335
Registration
5071067
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
07/02/2026
Trademark type
Word
Nice classes
5
Filing date
06/12/2015
Registration date
11/01/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2023
Last transaction
07/02/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
09/08/2004
First use in commerce
09/08/2004
Drawing code
4
Owner type
03
Owner location
Palo Alto, CA, US
Examiner
MONINGHOFF, KIM TERESA
Law office
M40
Current location
TMO LAW OFFICE 113
Holders and representatives
Holders
Jazz Pharmaceuticals, Inc.
Representatives
Michael Olsen Winthrop & Weinstine, P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
House mark for a line of pharmaceuticals for the treatment and prevention of cancerpsychiatric diseases and disorderscentral nervous system conditionspainsleep disordersnarcolepsyschizophreniafor use in oncology and hematology; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations acting on the central nervous system; pain relief medication; pharmaceutical preparations for use in the treatment and/or management of sleep disorders; pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of schizophrenia; pharmaceutical preparations for use in oncology and hematology
Publications
History of USPTO decisions and trademark events.
39 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/11/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/01/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/09/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/09/2023
E815
TEAS SECTION 8 & 15 RECEIVED
09/29/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/01/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/26/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/15/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/15/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/23/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/23/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/16/2016
PUBO
PUBLISHED FOR OPPOSITION
08/16/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/27/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/14/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
07/14/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/14/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
07/14/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/14/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/04/2016
GNFR
FINAL REFUSAL E-MAILED
04/04/2016
CNFR
FINAL REFUSAL WRITTEN
04/04/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/29/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/28/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/28/2016
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
09/28/2015
GPRA
PRIORITY ACTION E-MAILED
09/28/2015
CPRA
PRIORITY ACTION WRITTEN
09/28/2015
DOCK
ASSIGNED TO EXAMINER
09/22/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/24/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/17/2015
NWAP
NEW APPLICATION ENTERED
06/16/2015
Continuous trademark protection
Get notified about every new filing that threatens JAZZ PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.